
Loblaw Companies (L.TO) Earnings
Price: $191.99
Market Cap: $57.67B
Market Cap: $57.67B
Revenue (TTM): $61.01B
Net Income: $2.17B
Net Income: $2.17B
P/E Ratio: 26.66
EPS (TTM): $7.20
EPS (TTM): $7.20
Earnings Dates
Loblaw Companies (L.TO) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date: April 29, 2025
- Time of Day: Before Market Open
- Estimated EPS: $1.87
Last Earnings Report
- Date: February 20, 2025
- EPS: $1.53
- EPS Estimate: $1.54
Loblaw Companies's next earnings report is scheduled for April 29, 2025.
In its last earnings report on February 20, 2025, Loblaw Companies reported earnings per share (EPS) of $1.53, compared to an estimated EPS of $1.54. The company reported revenue of $14.95B, compared to an estimated revenue of $10.39B.
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q4 | 2024 | 2025-02-20 | $1.54 | $1.53 |
Read Transcript | Q3 | 2024 | 2024-11-13 | $2.45 | $2.50 |
Read Transcript | Q2 | 2024 | 2024-07-25 | $2.14 | $2.15 |
Read Transcript | Q1 | 2024 | 2024-05-01 | $1.70 | $1.72 |
Read Transcript | Q4 | 2023 | 2024-02-22 | $1.90 | $2.00 |
Read Transcript | Q3 | 2023 | 2023-11-15 | $2.22 | $2.26 |
Read Transcript | Q2 | 2023 | 2023-07-26 | $1.91 | $1.94 |
Read Transcript | Q1 | 2023 | 2023-05-03 | $1.55 | $1.55 |
Read Transcript | Q4 | 2022 | 2023-02-23 | $1.71 | $1.76 |
Read Transcript | Q3 | 2022 | 2022-11-16 | $1.96 | $2.01 |
Read Transcript | Q2 | 2022 | 2022-07-27 | N/A | N/A |
Read Transcript | Q1 | 2022 | 2022-05-04 | N/A | N/A |
Read Transcript | Q4 | 2021 | 2022-02-26 | N/A | N/A |
Read Transcript | Q3 | 2021 | 2021-11-17 | N/A | N/A |
Read Transcript | Q2 | 2021 | 2021-07-28 | N/A | N/A |
Read Transcript | Q1 | 2021 | 2021-05-08 | N/A | N/A |
Read Transcript | Q4 | 2020 | 2021-02-28 | N/A | N/A |
Read Transcript | Q3 | 2020 | 2020-11-13 | N/A | N/A |
Read Transcript | Q2 | 2020 | 2020-07-23 | N/A | N/A |
Read Transcript | Q1 | 2020 | 2020-04-29 | N/A | N/A |
Read Transcript | Q4 | 2019 | 2020-02-20 | N/A | N/A |
Read Transcript | Q3 | 2019 | 2019-11-13 | N/A | N/A |
Read Transcript | Q2 | 2019 | 2019-07-24 | N/A | N/A |
Read Transcript | Q1 | 2019 | 2019-05-01 | N/A | N/A |
Read Transcript | Q4 | 2018 | 2019-02-21 | N/A | N/A |
Read Transcript | Q3 | 2018 | 2018-11-15 | N/A | N/A |
Read Transcript | Q2 | 2018 | 2018-07-25 | N/A | N/A |
Read Transcript | Q1 | 2018 | 2018-05-02 | N/A | N/A |
Read Transcript | Q4 | 2017 | 2018-02-22 | N/A | N/A |
Read Transcript | Q3 | 2017 | 2017-11-15 | N/A | N/A |
Read Transcript | Q2 | 2017 | 2017-07-26 | N/A | N/A |
Read Transcript | Q1 | 2017 | 2017-05-03 | N/A | N/A |
Read Transcript | Q4 | 2016 | 2017-02-23 | N/A | N/A |
Read Transcript | Q3 | 2016 | 2016-11-16 | N/A | N/A |
Read Transcript | Q2 | 2016 | 2016-07-27 | N/A | N/A |
Read Transcript | Q1 | 2016 | 2016-05-08 | N/A | N/A |
Earnings History
Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
---|---|---|---|---|
February 20, 2025 | $1.53 | $1.54 | $14.95B | $10.39B |
November 13, 2024 | $2.50 | $2.45 | $18.54B | $13.79B |
July 25, 2024 | $2.15 | $2.14 | $13.95B | $10.35B |
May 01, 2024 | $1.72 | $1.70 | $13.58B | $9.94B |
February 22, 2024 | $2.00 | $1.90 | $14.53B | $14.60B |
November 15, 2023 | $2.26 | $2.22 | $18.27B | $18.15B |
July 26, 2023 | $1.94 | $1.91 | $13.74B | $18.15B |
May 03, 2023 | $1.55 | $1.55 | $12.99B | $13.20B |
February 23, 2023 | $1.76 | $1.71 | $14.01B | $13.75B |
November 16, 2022 | $2.01 | $1.96 | $17.39B | $16.83B |
July 27, 2022 | $1.69 | $1.61 | $12.85B | $12.98B |
May 04, 2022 | $1.36 | $1.32 | $12.26B | $12.30B |
February 24, 2022 | $1.52 | $1.36 | $12.76B | $12.63B |
November 17, 2021 | $1.59 | $1.48 | $16.05B | $- |
July 28, 2021 | $1.35 | $1.21 | $12.49B | $- |
May 05, 2021 | $1.13 | $0.87 | $11.87B | $- |
February 25, 2021 | $1.26 | $1.25 | $13.29B | $- |
Annual Earnings
Annual Revenue
$61.01B
Fiscal Year 2024Annual Net Income
$2.17B
Fiscal Year 2024Annual EPS
$7.06
Fiscal Year 2024Quarterly Earnings
Revenue
$14.95B
Quarter Ending December 31, 2024Net Income
$469.00M
Quarter Ending December 31, 2024EPS
$1.53
Quarter Ending December 31, 2024Earnings Metrics
Earnings Yield
3.76%
Year Ending December 31, 2024P/E Ratio
26.58
Year Ending December 31, 2024Revenue Per Share
$199.98
Year Ending December 31, 2024Earnings Yield (TTM)
3.75%
Trailing Twelve MonthsP/E Ratio (TTM)
26.66
Trailing Twelve MonthsRevenue Per Share (TTM)
$202.37
Trailing Twelve MonthsFrequently Asked Questions
Loblaw Companies's next earnings date is scheduled for April 29, 2025. The earnings call is expected to take place before market open.
In its last earnings report on February 20, 2025, Loblaw Companies reported earnings per share (EPS) of $1.53, compared to an estimated EPS of $1.54. The company reported revenue of $14.95B, compared to an estimated revenue of $10.39B.
Loblaw Companies's current Price-to-Earnings (P/E) ratio is 26.58. The trailing twelve months (TTM) P/E ratio is 26.66. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2024, Loblaw Companies reported total revenue of $61.01B and net income of $2.17B. This represents a net profit margin of 0.0355819976.
Loblaw Companies's earnings yield is 3.76%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
Loblaw Companies's return on equity (ROE) is 19.57%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
Loblaw Companies's gross profit margin is 32.33%. This indicates that for every dollar of revenue, the company retains $0.32 as gross profit after accounting for the cost of goods sold.
Related Metrics
Explore detailed financial metrics and analysis for L.TO.